MONITAIR-OSARemote Monitoring for CPAP Adherence in Obstructive Sleep Apnea
Standard Coaching (SOC)
+ MonitAir RPM
Treatment Adherence and Compliance+11
+ Apnea
+ Behavior
Treatment Study
Summary
Study start date: February 5, 2024
Actual date on which the first participant was enrolled.Obstructive sleep apnea (OSA) is a common sleep disorder that can lead to serious health issues like high blood pressure, heart problems, and diabetes, affecting overall quality of life. The typical treatment involves using a CPAP machine, which helps keep the airway open during sleep. However, many people struggle to keep up with this treatment. This study is exploring whether using a remote patient monitoring platform called MonitAir can help improve how consistently people use their CPAP machines. MonitAir allows healthcare providers to track patients' CPAP use remotely and provide timely support, aiming to enhance patient commitment to treatment and improve health outcomes. Participants in this study are individuals recently diagnosed with OSA who are beginning CPAP therapy. They are divided into two groups: one receives regular coaching, and the other gets additional support through the MonitAir platform. This platform includes weekly reviews of CPAP data, automated messages, monthly telehealth check-ins, and extra doctor consultations if needed. The study measures how often participants use their CPAP machines over 30, 60, and 90 days, based on specific guidelines. It also looks at other factors like patient satisfaction, quality of sleep, and any issues with the CPAP masks. All participants are monitored for typical side effects, with no additional risks expected from using the MonitAir system.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.200 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location